SuperworthBausch Health Companies EPS BHC
Diluted earnings per share by quarter and over the last twelve months, from 2009.
- Last 12 months, to Jun 30, 2026
- −$2.96
- Latest quarter, Q2 FY26
- $0.68
- +70% on a year earlier
- Fiscal year 2025
- $0.42
Bausch Health Companies' earnings per share was −$2.96 over the twelve months to Jun 30, 2026, down 1238% on a year earlier.
In its latest quarter, Q2 FY26, it was $0.68, up 70% on the same quarter a year before.
Earnings per share over time
Fiscal year by fiscal year
| Fiscal year | EPS | Change |
|---|---|---|
| FY2025 | $0.42 | n/a |
| FY2024 | −$0.12 | n/a |
| FY2023 | −$1.62 | n/a |
| FY2022 | −$0.62 | n/a |
| FY2021 | −$2.66 | n/a |
| FY2020 | −$1.58 | n/a |
| FY2019 | −$5.08 | n/a |
| FY2018 | −$11.83 | −273% |
| FY2017 | $6.82 | n/a |
| FY2016 | −$6.92 | n/a |
| FY2015 | −$0.85 | −133% |
| FY2014 | $2.58 | n/a |
| FY2013 | −$2.61 | n/a |
| FY2012 | −$0.38 | −176% |
| FY2011 | $0.50 | n/a |
Each fiscal year is the twelve months to its fourth quarter.
Quarter by quarter
| Quarter | Ended | EPS | On a year earlier | Last 12 months |
|---|---|---|---|---|
| Q2 FY26 | $0.68 | +70% | −$2.96 | |
| Q1 FY26 | −$3.82 | n/a | −$3.24 | |
| Q4 FY25 | −$0.30 | −220% | $0.42 | |
| Q3 FY25 | $0.48 | n/a | $0.97 | |
| Q2 FY25 | $0.40 | +1233% | $0.26 | |
| Q1 FY25 | −$0.16 | n/a | −$0.11 | |
| Q4 FY24 | $0.25 | n/a | −$0.12 | |
| Q3 FY24 | −$0.23 | n/a | −$0.48 | |
| Q2 FY24 | $0.03 | −57% | −$1.28 | |
| Q1 FY24 | −$0.17 | n/a | −$1.24 | |
| Q4 FY23 | −$0.11 | n/a | −$1.62 | |
| Q3 FY23 | −$1.03 | −194% | −$2.64 |
Against its peers
Companies in Drug Manufacturers - General nearest Bausch Health Companies' size, closest first, today.
| Company | EPS, 12 months | Growth |
|---|---|---|
| BHCBausch Health Companies | −$2.96 | −1238% a year |
| PBHPrestige Consumer Healthcare | $3.57 | −16% a year |
| HRMYHarmony Biosciences | $3.09 | −0% a year |
| NRIXNurix Therapeutics | $2.31 | |
| ANIPANI Pharmaceuticals | $4.70 | |
| OGNOrganon | $0.77 | −71% a year |
| PAHCPhibro Animal Health | $2.44 | +107% a year |
| LQDALiquidia | $1.39 | |
| ARQTArcutis Biotherapeutics | $0.22 | |
| ANABAnaptysbio | $4.57 | |
| PCRXPacira BioSciences | $0.35 | |
| Peer median | $2.38 |
What the EPS figure tells you
Net income divided by diluted shares. The denominator of PE.
One-off charges and gains swing it. The TTM view smooths a single odd quarter.
More on Bausch Health Companies
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.